Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification and preliminary validation of synovial tissue-specific genes and their-mediated biological mechanisms in rheumatoid arthritis. | Int Immunopharmacol | 2023 | 36940554 | PubTator, text mining | PubMed |
| Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma. | Cancer Biomark | 2023 | 36938730 | PubTator, text mining | PubMed |
| Hyaluronan in liver fibrosis: basic mechanisms, clinical implications, and therapeutic targets. | Hepatol Commun | 2023 | 36930869 | PubTator, text mining | PubMed |
| Screening of potential hub genes and key pathways associated with breast cancer by bioinformatics tools. | Medicine (Baltimore) | 2023 | 36930083 | PubTator, text mining | PubMed |
| SHock-INduced Endotheliopathy (SHINE): A mechanistic justification for viscoelastography-guided resuscitation of traumatic and non-traumatic shock. | Front Physiol | 2023 | 36923287 | PubTator, text mining | PubMed |
| Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments. | Mol Cancer | 2023 | 36906534 | PubTator, text mining | PubMed |
| Molecular Pathways Implicated in Radioresistance of Glioblastoma Multiforme: What Is the Role of Extracellular Vesicles? | Int J Mol Sci | 2023 | 36902314 | PubTator, text mining | PubMed |
| Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning. | Sci Rep | 2023 | 36882493 | PubTator, text mining | PubMed |
| Single-cell and bulk RNA sequencing identifies T cell marker genes score to predict the prognosis of pancreatic ductal adenocarcinoma. | Sci Rep | 2023 | 36878969 | PubTator, text mining | PubMed |
| Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma. | Front Genet | 2023 | 36873946 | PubTator, text mining | PubMed |
| Construction of a Novel Diagnostic Model Based on Ferroptosis-Related Genes for Hepatocellular Carcinoma Using Machine and Deep Learning Methods. | J Oncol | 2023 | 36873737 | PubTator, text mining | PubMed |
| Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis. | Cancer Genomics Proteomics | 2023 | 36870687 | PubTator, text mining | PubMed |
| Cell surface markers for mesenchymal stem cells related to the skeletal system: A scoping review. | Heliyon | 2023 | 36865479 | PubTator, text mining | PubMed |
| Integrative Analysis Revealed LINC00847 as a Potential Target of Tumor Immunotherapy. | Appl Biochem Biotechnol | 2023 | 36864364 | PubTator, text mining | PubMed |
| Identification of GNG7 as a novel biomarker and potential therapeutic target for gastric cancer via bioinformatic analysis and in vitro experiments. | Aging (Albany NY) | 2023 | 36863706 | PubTator, text mining | PubMed |
| Hyaluronan-Cyclodextrin Conjugates as Doxorubicin Delivery Systems. | Pharmaceutics | 2023 | 36839696 | PubTator, text mining | PubMed |
| Targeting the Tumor Immune Microenvironment Could Become a Potential Therapeutic Modality for Aggressive Pituitary Adenoma. | Brain Sci | 2023 | 36831707 | PubTator, text mining | PubMed |
| Role of Hyaluronic Acid in Selected Malignant Neoplasms in Women. | Biomedicines | 2023 | 36830841 | PubTator, text mining | PubMed |
| Identification of potential biomarkers for colorectal cancer by clinical database analysis and Kaplan-Meier curves analysis. | Medicine (Baltimore) | 2023 | 36820595 | PubTator, text mining | PubMed |
| The Impaired Wound Healing Process Is a Major Factor in Remodeling of the Corneal Epithelium in Adult and Adolescent Patients With Keratoconus. | Invest Ophthalmol Vis Sci | 2023 | 36811882 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=16